American Journal of Physiology-Heart and Circulatory Physiology · 1998 · 81 citations · 18 references
Life SciencesCell BiologyPhysiologyCell PhysiologyMolecular Cell BiologyMolecular PhysiologyCardiac PhysiologyCardiovascular Molecular PhysiologyCardiovascular PhysiologyCell Cycle TransitionsCyclin-dependent KinasesHeart DevelopmentCyclin A RegulationCyclin E RegulationCyclin RegulationCyclin-dependent Kinase RegulationCyclinsMitotic CyclinsSham Manipulation ControlsTranscriptional Regulation By Cyclin-dependent Kinases
Cell cycle regulatory molecules are implicated in cardiomyocyte hypertrophy. We have investigated protein expression of cyclins A, D1-3, and E and cyclin-dependent kinases (CDKs) 2, 4, 5, and 6 in left ventricular (LV) tissues during the development of LV hypertrophy in rats following aortic constriction (AC). Compared with their expression in sham-operated controls (SH), expression of cyclins D2 and D3 and of CDK4 and CDK6 increased significantly from day 3 to day 21 after AC concomitant with increased LV mass. However, no significant difference was observed for CDK2 or CDK5. Cyclins A, D1, and E were undetectable. In vitro kinase activities of CDK4 and CDK6 increased approximately 70% from day 7 to day 14 in AC myocytes compared with SH myocytes (P < 0.03). Fluorescence-activated cell sorter analysis revealed a G0/G1 to G2/M phase progression in AC myocyte nuclei (22.0 +/- 1.1% in G2/M) by day 7 postoperation compared with progression in SH myocyte nuclei (14.0 +/- 0.8% in G2/M; P < 0.01). Thus an upregulation of certain cell cycle regulators is associated with cardiomyocyte hypertrophy.
18
p21 is a universal inhibitor of cyclin kinases
Yue Xiong, Gregory J. Hannon, Hui Zhang et al. · Nature · 1993 · 3.4K citations